|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, November 24, 2016 ) Global Markets Directs, 'Primary Biliary Cirrhosis Pipeline Review, H2 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Primary Biliary Cirrhosis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Primary Biliary Cirrhosis. Primary Biliary Cirrhosis Pipeline Review, Half Year is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team.
Download free Sample PDF report with TOC: http://www.researchmoz.us/enquiry.php?type=S&repid=184907
Scope
A snapshot of the global therapeutic scenario for Primary Biliary Cirrhosis.
A review of the Primary Biliary Cirrhosis products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
Coverage of products based on various stages of development ranging from discovery till registration stages.
A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
Coverage of the Primary Biliary Cirrhosis pipeline on the basis of route of administration and molecule type.
Key discontinued pipeline projects.
Latest news and deals relating to the products.
Read All Healthcare Market Research Reports @ http://www.researchmoz.us/healthcare-market-reports-56.html
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Global Markets Direct Report Coverage 6
Primary Biliary Cirrhosis Overview 7
Therapeutics Development 8
Pipeline Products for Primary Biliary Cirrhosis - Overview 8
Pipeline Products for Primary Biliary Cirrhosis - Comparative Analysis 9
Primary Biliary Cirrhosis - Therapeutics under Development by Companies 10
Primary Biliary Cirrhosis - Therapeutics under Investigation by Universities/Institutes 12
Primary Biliary Cirrhosis - Pipeline Products Glance 13
Late Stage Products 13
Clinical Stage Products 14
Early Stage Products 15
Primary Biliary Cirrhosis - Products under Development by Companies 16
Primary Biliary Cirrhosis - Products under Investigation by Universities/Institutes 17
Primary Biliary Cirrhosis - Companies Involved in Therapeutics Development 18
Johnson & Johnson 18
GlaxoSmithKline plc 19
AlbireoPharma 20
NovImmune SA 21
Intercept Pharmaceuticals, Inc. 22
Dr. Falk Pharma GmbH 23
Lumena Pharmaceuticals, Inc. 24
Primary Biliary Cirrhosis - Therapeutics Assessment 25
Assessment by Monotherapy Products 25
Contact Us:
Mr. Nachiket
Albany NY, United States - 12207
Tel: +1-518-621-2074 / Tel: 866-997-4948 (Us-Canada Toll Free)
Email: sales@researchmoz.us
Follow us on LinkedIn at: http://bit.ly/1TBmnVG
Follow me on Blogger at: http://healthcare-research-report.blogspot.in/
About ResearchMoz
ResearchMoz is the world's fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz's service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.
Researchmoz Global Pvt.Ltd
Researchmoz
+1-518-621-2074
sales@researchmoz.us
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
